CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 25 of 219 entries

View as:

Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)

Phase: N/A Priority: Normal

NCT ID: NCT00094627 Org: User:

Start: 11/30/04 End: 04/30/06 Due: 04/30/07

Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)

Phase: N/A Priority: Normal

NCT ID: NCT00420810 Org: User:

Start: 09/30/06 End: - Due: -

Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease

Phase: N/A Priority: Normal

NCT ID: NCT04149860 Org: User:

Start: 09/27/19 End: 07/19/23 Due: 07/19/24

A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments

Phase: N/A Priority: Normal

NCT ID: NCT04418765 Org: User:

Start: 06/01/20 End: 09/15/22 Due: 09/15/23

Efficacy of Lu 31-130 in Patients With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00770744 Org: User:

Start: 09/30/08 End: 11/30/09 Due: 11/30/10

Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)

Phase: N/A Priority: Normal

NCT ID: NCT01987960 Org: User:

Start: 12/31/13 End: 10/31/15 Due: 10/31/16

A Study to Evaluate Lu AG06466 in Participants With Fibromyalgia

Phase: N/A Priority: Normal

NCT ID: NCT04974359 Org: User:

Start: 06/24/21 End: 01/26/22 Due: 01/26/23

Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT02187809 Org: User:

Start: 03/31/15 End: 10/31/15 Due: 10/31/16

A Study Investigating Lu AG22515 in Healthy Adults

Phase: N/A Priority: Normal

NCT ID: NCT05136053 Org: User:

Start: 03/18/22 End: 08/05/23 Due: 08/05/24

Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension

Phase: N/A Priority: Normal

NCT ID: NCT02586623 Org: User:

Start: 02/11/16 End: 09/09/22 Due: 09/09/23

Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder

Phase: N/A Priority: Normal

NCT ID: NCT01148472 Org: User:

Start: 09/30/05 End: 11/30/06 Due: 11/30/07

A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

Phase: N/A Priority: Normal

NCT ID: NCT06701526 Org: User:

Start: 12/18/24 End: 06/05/26 Due: 06/05/27

Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge

Phase: N/A Priority: Normal

NCT ID: NCT01969617 Org: User:

Start: 11/30/13 End: - Due: -

Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal

NCT ID: NCT02919501 Org: User:

Start: 09/27/16 End: 04/27/17 Due: 04/27/18

Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy Subjects

Phase: N/A Priority: Normal

NCT ID: NCT04275115 Org: User:

Start: 02/10/20 End: 04/03/20 Due: 04/03/21

Efficacy of Lu 31-130 in Patients With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00768326 Org: User:

Start: 03/31/07 End: 11/30/09 Due: 11/30/10

Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke

Phase: N/A Priority: Normal

NCT ID: NCT00790920 Org: User:

Start: 12/31/08 End: - Due: -

Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State

Phase: N/A Priority: Normal

NCT ID: NCT03670082 Org: User:

Start: 09/05/18 End: 01/13/19 Due: 01/13/20

Bioequivalence Study Comparing Two Formulations of Escitalopram

Phase: N/A Priority: Normal

NCT ID: NCT01395433 Org: User:

Start: 01/31/10 End: - Due: -

Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil

Phase: N/A Priority: Normal

NCT ID: NCT01955161 Org: User:

Start: 10/31/13 End: 07/31/16 Due: 07/31/17

Bioequivalence Study of Lu AF35700

Phase: N/A Priority: Normal

NCT ID: NCT03394482 Org: User:

Start: 01/03/18 End: 10/05/18 Due: 10/05/19

Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

Phase: N/A Priority: Normal

NCT ID: NCT00761306 Org: User:

Start: 06/30/07 End: 10/31/08 Due: 10/31/09

Brexpiprazole in Patients With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT01810783 Org: User:

Start: 07/31/13 End: 12/31/15 Due: 12/31/16

Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men

Phase: N/A Priority: Normal

NCT ID: NCT02436486 Org: User:

Start: 05/31/15 End: - Due: -

Escitalopram in Patients With Social Anxiety Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00902226 Org: User:

Start: 03/31/09 End: 03/31/10 Due: 03/31/11

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)	NCT00094627	H. Lundbeck A/S	user2@example.com	None	2004-11-30	2006-04-30	2007-04-30	-	-	2025-07-14
Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)	NCT00420810	H. Lundbeck A/S	user2@example.com	None	2006-09-30	-	-	-	-	2025-07-14
Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease	NCT04149860	H. Lundbeck A/S	user2@example.com	None	2019-09-27	2023-07-19	2024-07-19	-	-	2025-07-14
A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments	NCT04418765	H. Lundbeck A/S	user2@example.com	None	2020-06-01	2022-09-15	2023-09-15	-	-	2025-07-14
Efficacy of Lu 31-130 in Patients With Schizophrenia	NCT00770744	H. Lundbeck A/S	user2@example.com	None	2008-09-30	2009-11-30	2010-11-30	-	-	2025-07-14
Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)	NCT01987960	H. Lundbeck A/S	user2@example.com	None	2013-12-31	2015-10-31	2016-10-31	-	-	2025-07-14
A Study to Evaluate Lu AG06466 in Participants With Fibromyalgia	NCT04974359	H. Lundbeck A/S	user2@example.com	None	2021-06-24	2022-01-26	2023-01-26	-	-	2025-07-14
Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome	NCT02187809	H. Lundbeck A/S	user2@example.com	None	2015-03-31	2015-10-31	2016-10-31	-	-	2025-07-14
A Study Investigating Lu AG22515 in Healthy Adults	NCT05136053	H. Lundbeck A/S	user2@example.com	None	2022-03-18	2023-08-05	2024-08-05	-	-	2025-07-14
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension	NCT02586623	H. Lundbeck A/S	user2@example.com	None	2016-02-11	2022-09-09	2023-09-09	-	-	2025-07-14
Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder	NCT01148472	H. Lundbeck A/S	user2@example.com	None	2005-09-30	2006-11-30	2007-11-30	-	-	2025-07-14
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications	NCT06701526	H. Lundbeck A/S	user2@example.com	None	2024-12-18	2026-06-05	2027-06-05	-	-	2025-07-14
Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge	NCT01969617	H. Lundbeck A/S	user2@example.com	None	2013-11-30	-	-	-	-	2025-07-14
Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder	NCT02919501	H. Lundbeck A/S	user2@example.com	None	2016-09-27	2017-04-27	2018-04-27	-	-	2025-07-14
Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy Subjects	NCT04275115	H. Lundbeck A/S	user2@example.com	None	2020-02-10	2020-04-03	2021-04-03	-	-	2025-07-14
Efficacy of Lu 31-130 in Patients With Schizophrenia	NCT00768326	H. Lundbeck A/S	user2@example.com	None	2007-03-31	2009-11-30	2010-11-30	-	-	2025-07-14
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke	NCT00790920	H. Lundbeck A/S	user2@example.com	None	2008-12-31	-	-	-	-	2025-07-14
Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State	NCT03670082	H. Lundbeck A/S	user2@example.com	None	2018-09-05	2019-01-13	2020-01-13	-	-	2025-07-14
Bioequivalence Study Comparing Two Formulations of Escitalopram	NCT01395433	H. Lundbeck A/S	user2@example.com	None	2010-01-31	-	-	-	-	2025-07-14
Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil	NCT01955161	H. Lundbeck A/S	user2@example.com	None	2013-10-31	2016-07-31	2017-07-31	-	-	2025-07-14
Bioequivalence Study of Lu AF35700	NCT03394482	H. Lundbeck A/S	user2@example.com	None	2018-01-03	2018-10-05	2019-10-05	-	-	2025-07-14
Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults	NCT00761306	H. Lundbeck A/S	user2@example.com	None	2007-06-30	2008-10-31	2009-10-31	-	-	2025-07-14
Brexpiprazole in Patients With Schizophrenia	NCT01810783	H. Lundbeck A/S	user2@example.com	None	2013-07-31	2015-12-31	2016-12-31	-	-	2025-07-14
Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men	NCT02436486	H. Lundbeck A/S	user2@example.com	None	2015-05-31	-	-	-	-	2025-07-14
Escitalopram in Patients With Social Anxiety Disorder	NCT00902226	H. Lundbeck A/S	user2@example.com	None	2009-03-31	2010-03-31	2011-03-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance